Moreover, breast cancer is considered hormone-receptor-positive when it possesses estrogen receptor (ER) and/or progesterone receptor (PR), whereas a tumor is considered as triple negative breast cancer when lacking in ER, PR and HER2 expression. Here, PGR is linked to triple-negative breast carcinoma.